Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Viviany Rodrigues Taqueti, M.D.

Co-Author

This page shows the publications co-authored by Viviany Taqueti and Sharmila Dorbala.
Connection Strength

3.839
  1. The role of positron emission tomography in the evaluation of myocardial ischemia in women. J Nucl Cardiol. 2016 10; 23(5):1008-1015.
    View in: PubMed
    Score: 0.653
  2. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2022 04; 29(2):440-446.
    View in: PubMed
    Score: 0.217
  3. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 05 10; 62(5):716-722.
    View in: PubMed
    Score: 0.217
  4. Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease. J Nucl Cardiol. 2021 08; 28(4):1395-1408.
    View in: PubMed
    Score: 0.201
  5. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
    View in: PubMed
    Score: 0.195
  6. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol. 2018 08 14; 72(7):707-717.
    View in: PubMed
    Score: 0.188
  7. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
    View in: PubMed
    Score: 0.182
  8. Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations. J Nucl Cardiol. 2017 08; 24(4):1402-1426.
    View in: PubMed
    Score: 0.173
  9. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017 02 07; 135(6):566-577.
    View in: PubMed
    Score: 0.166
  10. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35.
    View in: PubMed
    Score: 0.145
  11. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015 Jan 06; 131(1):19-27.
    View in: PubMed
    Score: 0.145
  12. Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery Disease. Circ Cardiovasc Imaging. 2022 06; 15(6):e013987.
    View in: PubMed
    Score: 0.061
  13. Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) Study. JAMA Cardiol. 2022 01 01; 7(1):93-99.
    View in: PubMed
    Score: 0.059
  14. Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer. J Nucl Cardiol. 2021 Nov 24.
    View in: PubMed
    Score: 0.059
  15. Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. Eur Heart J. 2021 Sep 07.
    View in: PubMed
    Score: 0.058
  16. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. JACC Cardiovasc Imaging. 2022 02; 15(2):312-321.
    View in: PubMed
    Score: 0.058
  17. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 11; 14(11):2212-2220.
    View in: PubMed
    Score: 0.056
  18. Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2022 06; 29(3):1234-1244.
    View in: PubMed
    Score: 0.055
  19. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2021 12; 28(6):2976-2987.
    View in: PubMed
    Score: 0.054
  20. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
    View in: PubMed
    Score: 0.054
  21. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022 Feb; 29(1):37-42.
    View in: PubMed
    Score: 0.053
  22. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
    View in: PubMed
    Score: 0.051
  23. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2021 10; 28(5):1988-1997.
    View in: PubMed
    Score: 0.051
  24. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.050
  25. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
    View in: PubMed
    Score: 0.049
  26. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
    View in: PubMed
    Score: 0.047
  27. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol. 2018 09; 4(9):1200-1210.
    View in: PubMed
    Score: 0.047
  28. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
    View in: PubMed
    Score: 0.045
  29. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
    View in: PubMed
    Score: 0.045
  30. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol. 2017 12 05; 70(22):2835-2837.
    View in: PubMed
    Score: 0.045
  31. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509.
    View in: PubMed
    Score: 0.044
  32. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017 Dec 12; 136(24):2325-2336.
    View in: PubMed
    Score: 0.044
  33. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
    View in: PubMed
    Score: 0.043
  34. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
    View in: PubMed
    Score: 0.041
  35. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017 02; 24(1):86-99.
    View in: PubMed
    Score: 0.040
  36. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9.
    View in: PubMed
    Score: 0.039
  37. Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". Circulation. 2015 Mar 17; 131(11):e376.
    View in: PubMed
    Score: 0.037
  38. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014 Jun 17; 129(24):2518-27.
    View in: PubMed
    Score: 0.035
  39. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014 Feb; 55(2):248-55.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.